These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 17805489)
61. Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost. Herndon LW; Asrani SG; Williams GH; Challa P; Lee PP Arch Ophthalmol; 2002 Jun; 120(6):847-9. PubMed ID: 12049597 [No Abstract] [Full Text] [Related]
62. Acute visual loss due to serous retinal detachment from acquired optic pit may be a rare presentation of primary open-angle glaucoma. Rath EZ; Rumelt S Can J Ophthalmol; 2007 Apr; 42(2):339-40. PubMed ID: 17392876 [No Abstract] [Full Text] [Related]
63. [Pathophysiology of macular diseases--morphology and function]. Iida T Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310 [TBL] [Abstract][Full Text] [Related]
64. Anatomy and function of the macula after surgery for retinal detachment complicated by proliferative vitreoretinopathy. Kiss CG; Richter-Müksch S; Sacu S; Benesch T; Velikay-Parel M Am J Ophthalmol; 2007 Dec; 144(6):872-877. PubMed ID: 17937924 [TBL] [Abstract][Full Text] [Related]
65. Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment. Ueda T; Gomi F; Suzuki M; Sakaguchi H; Sawa M; Kamei M; Nishida K Retina; 2012 Feb; 32(2):308-13. PubMed ID: 21869614 [TBL] [Abstract][Full Text] [Related]
66. Spontaneous resolution of a shallow detachment of the macula in a highly myopic eye. Polito A; Lanzetta P; Del Borrello M; Bandello F Am J Ophthalmol; 2003 Apr; 135(4):546-7. PubMed ID: 12654378 [TBL] [Abstract][Full Text] [Related]
67. Increased eyelid pigmentation associated with use of latanoprost. Kook MS; Lee K Am J Ophthalmol; 2000 Jun; 129(6):804-6. PubMed ID: 10926995 [TBL] [Abstract][Full Text] [Related]
68. CME and anterior uveitis with latanoprost use. Thorne JE; Maguire AM; Lanciano R Ophthalmology; 1998 Nov; 105(11):1981-3. PubMed ID: 9818590 [No Abstract] [Full Text] [Related]
69. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%. Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191 [TBL] [Abstract][Full Text] [Related]
70. Intravitreal injection of ranibizumab for recovery of macular function in eyes with subfoveal polypoidal choroidal vasculopathy. Ogino K; Tsujikawa A; Yamashiro K; Ooto S; Oishi A; Nakata I; Miyake M; Yoshimura N Invest Ophthalmol Vis Sci; 2013 May; 54(5):3771-9. PubMed ID: 23661367 [TBL] [Abstract][Full Text] [Related]
71. A correlation between latanoprost-induced conjunctival hyperemia and intraocular pressure-lowering effect. Kobayashi H; Kobayashi K J Glaucoma; 2011 Jan; 20(1):3-6. PubMed ID: 20520573 [TBL] [Abstract][Full Text] [Related]
72. A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study. Weinreb RN; Ong T; Scassellati Sforzolini B; Vittitow JL; Singh K; Kaufman PL; Br J Ophthalmol; 2015 Jun; 99(6):738-45. PubMed ID: 25488946 [TBL] [Abstract][Full Text] [Related]
73. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment. Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913 [TBL] [Abstract][Full Text] [Related]